Bio-Connect

Search results: LymphoTrack Dx MiSeq

205 to 216 of 275 products
Sort by
Product group Antibodies
Aviva Systems Biology
ApplicationsWestern Blot
ReactivityHuman
TargetHLA-DQA2
  • SizePrice
Product group Antibodies
Aviva Systems Biology
ApplicationsWestern Blot
ReactivityHuman
TargetHLA-DQA2
  • SizePrice
Product group Antibodies
Aviva Systems Biology
ApplicationsWestern Blot
ReactivityHuman
TargetHLA-DQA2
  • SizePrice
Product group Antibodies
Aviva Systems Biology
ApplicationsWestern Blot
ReactivityHuman
TargetHLA-DQA2
  • SizePrice
WB Suggested Anti-HLA-DQA2 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:1562500; Positive Control: 721_B cell lysate;HLA-DQA2 is supported by BioGPS gene expression data to be expressed in 721_B
Product group Antibodies
OriGene
ApplicationsWestern Blot
ReactivityHuman
TargetHLA-DQA2
  • SizePrice
WB Suggested Anti-HLA-DQA2 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:312500; Positive Control: Human brain
Product group Antibodies
OriGene
ApplicationsWestern Blot
ReactivityHuman
TargetHLA-DQA2
  • SizePrice
Immunohistochemistry of paraffin-embedded Human cervical cancer tissue using TA368503 (HLA-DQA2 Antibody) at dilution 1/20 (Original magnification: x200)
Product group Antibodies
OriGene
ApplicationsImmunoHistoChemistry
ReactivityHuman
TargetHLA-DQA2
  • SizePrice
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY HLA-DQA2 (RC223979, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-HLA-DQA2 (1:500).
Product group Antibodies
OriGene
ApplicationsWestern Blot
ReactivityHuman
TargetHLA-DQA2
  • SizePrice
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY HLA-DQA2 (RC223979, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-HLA-DQA2 (1:500).
Product group Antibodies
OriGene
ApplicationsWestern Blot
ReactivityHuman
TargetHLA-DQA2
  • SizePrice
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY HLA-DQA2 (RC223979, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-HLA-DQA2 (1:500).
Product group Antibodies
OriGene
ApplicationsWestern Blot
ReactivityHuman
TargetHLA-DQA2
  • SizePrice
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY HLA-DQA2 (RC223979, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-HLA-DQA2 (1:500).
Product group Antibodies
OriGene
ApplicationsWestern Blot
ReactivityHuman
TargetHLA-DQA2
  • SizePrice
HEK293T cells were transfected with the pCMV6-ENTRY control (Cat# PS100001, Left lane) or pCMV6-ENTRY HLA-DQA2 (Cat# RC223979, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-HLA-DQA2 (Cat# TA812936)(1:500).
Product group Antibodies
OriGene
ApplicationsWestern Blot
ReactivityHuman
TargetHLA-DQA2
  • SizePrice